Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Opioid receptor signalling mechanisms.

M Connor1, M D Christie

  • 1Department of Pharmacology, University of Sydney, New South Wales, Australia. markc@pharmacol.usyd.edu.au

Clinical and Experimental Pharmacology & Physiology
|July 16, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cupriavidus spp. and other waterborne organisms in healthcare water systems across the UK.

The Journal of hospital infection·2022
Same author

A systematic review and meta-analysis of the diagnostic accuracy of biparametric prostate MRI for prostate cancer in men at risk.

Prostate cancer and prostatic diseases·2020
Same author

Factors Influencing the Prevalence of Animal Cruelty During Adolescence.

Journal of interpersonal violence·2018
Same author

Themed section.

British journal of pharmacology·2014
Same author

β-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons.

British journal of pharmacology·2014
Same author

Sex differences in the expression of serotonin-synthesizing enzymes in mouse trigeminal ganglia.

Neuroscience·2011

Opioid receptors (mu, delta, kappa, ORL1) signal through G-proteins, but their specific coupling varies. Cellular effects depend more on G-protein expression than receptor type, challenging previous assumptions.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Neuroscience

Background:

  • Three main opioid receptors (mu, delta, kappa) and a related ORL1 receptor are known.
  • Opioid receptors mediate cellular effects through G-protein activation.
  • The specific G-protein interactions and signaling pathways are complex and not fully understood.

Purpose of the Study:

  • To investigate the G-protein coupling profiles of different opioid receptors.
  • To determine the influence of opioid receptor type versus G-protein expression on cellular signaling outcomes.
  • To clarify the mechanisms underlying opioid receptor-mediated cellular effects.

Main Methods:

  • Analysis of opioid receptor interactions with various G-protein alpha-subunits (pertussis toxin-sensitive and insensitive).

Related Experiment Videos

  • Examination of differential coupling efficiencies between opioid receptors and specific G-proteins.
  • Investigation of potential G-protein-independent signaling pathways.

    • Main Results:

    • All opioid receptors interact with multiple G-proteins, with some preferential coupling observed (e.g., mu/delta/kappa to Go/Gi2, delta to G16).
    • Opioid receptors show limited interaction with Gs and mu receptors do not activate Gq/G11/G12/G13/G14.
    • Evidence suggests G-protein-independent signaling for mu and ORL1 receptors.
    • Cellular response is primarily dictated by the expressed G-protein and effector profile, not solely by the opioid receptor type.

    Conclusions:

    • Opioid receptor signaling is complex, involving diverse G-protein interactions.
    • The cellular context (G-protein and effector expression) is a critical determinant of opioid receptor function.
    • Previous notions of strict, intrinsic effector preferences for specific opioid receptor types are likely inaccurate.